23andMe provides direct-to-consumer DNA testing to give individuals insights about their ancestry, genetic traits, and health risks. Customers order a saliva-based testing kit, mail back a sample, and receive personalized reports based on genotyping the sample. The product includes optional subscription updates that add new findings as genetic science progresses. The company distinguishes itself with a large, active user base and a substantial anonymized genetic database that enables collaborations with research institutions and pharmaceutical companies. These data partnerships support genetic research and potential drug discoveries while driving additional revenue. Overall, the goal is to help people understand their genes and family history while contributing to broader scientific knowledge through data-driven research.
Company Size
501-1,000
Company Stage
IPO
Headquarters
Sunnyvale, California
Founded
2006
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?